Kyung-han B. Lee
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 179 publications
Enhanced Efficacy and Safety of 177Lu-Anti-CD25 Radioimmunotherapy by Combination with Targeted Anticancer Agents.
Journal: Molecular pharmaceutics
Published: March 03, 2026
Tracking MAPK-Dependent CD38 Upregulation by All-Trans Retinoic Acid in Human Leukemia Using 89Zr Immuno-PET.
Journal: Molecular pharmaceutics
Published: February 07, 2026
Minimal Additional Effect of Heparin Bolus Beyond Prolonged Fasting on Cardiac 18F-FDG Suppression in Infectious Disease PET/CT Evaluation: Inverse Association Between Myocardial 18F-FDG Uptake and CRP.
Journal: Nuclear medicine and molecular imaging
Published: November 25, 2025
Identification and Validation of a Novel Theranostic Target in Triple Negative Breast Cancer with Transcriptomics and Protein Analyses.
Journal: Breast cancer (Dove Medical Press)
Published: September 24, 2025
177Lu-Anti-CD25 Antibody for Interleukin-2 Receptor-α-Targeted Radioimmunotherapy of SUDHL1 Lymphomas in Mice.
Journal: Molecular pharmaceutics
Published: May 23, 2025
18F-Fluorocholine PET/CT as an Imaging Biomarker in Patients With Hepatocellular Carcinoma Receiving Atezolizumab Plus Bevacizumab.
Journal: Anticancer research
Published: January 27, 2025
Comparative Study of Dimeric Fibroblast Activation Protein-Targeting Radioligands Labeled with Fluorine-18, Copper-64, and Gallium-68.
Journal: Molecular pharmaceutics
Published: December 30, 2024
Genomic profiling of intimal sarcoma reveals molecular subtypes with distinct tumor microenvironments and therapeutic implications.
Journal: ESMO open
Published: September 04, 2024
Erratum: Centrality-Dependent Modification of Jet-Production Rates in Deuteron-Gold Collisions at sqrt[s_{NN}]=200 GeV [Phys. Rev. Lett. 116, 122301 (2016)].
Journal: Physical review letters
Published: August 22, 2024
Risk Factors for Rapid Cognitive Decline in Amyloid-Negative Individuals Without Cognitive Impairment or With Early-Stage Cognitive Loss in Screening Tests.
Journal: Clinical nuclear medicine
Published: August 01, 2024
Improved Limit on Neutrinoless Double Beta Decay of ^{100}Mo from AMoRE-I.
Journal: Physical review letters
Published: July 08, 2024
Imaging Very Late Antigen-4 on MOLT4 Leukemia Tumors with Cysteine Site-Specific 89Zr-Labeled Natalizumab Immuno-Positron Emission Tomography.
Journal: Molecular pharmaceutics
Published: January 29, 2024
Last Updated: 09/26/2026